Studies have shown that HMGA1 is involved in chemoresistance to platinum-based drugs (cisplatin), imatinib, 5-fluorouracil (5-FU), methotrexate, gemcitabine, and cyclophosphamide in various cancers 59-68. Here, HMGA1 is linked to cancer.